- 全部删除
 
您的购物车当前为空
Ly-295501 (ILX-295501) 是一种新型磺脲类化合物,已被证明对多种实体肿瘤具有体内抗肿瘤活性,并已被用于卵巢癌、转移性癌、输卵管癌和原发性腹膜腔癌的治疗试验。


为众多的药物研发团队赋能,
让新药发现更简单!
Ly-295501 (ILX-295501) 是一种新型磺脲类化合物,已被证明对多种实体肿瘤具有体内抗肿瘤活性,并已被用于卵巢癌、转移性癌、输卵管癌和原发性腹膜腔癌的治疗试验。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 530  | In stock | |
| 5 mg | ¥ 1,250  | In stock | |
| 10 mg | ¥ 1,860  | In stock | |
| 25 mg | ¥ 3,530  | In stock | |
| 50 mg | ¥ 4,730  | In stock | |
| 100 mg | ¥ 7,150  | In stock | |
| 500 mg | ¥ 14,300  | In stock | 
| 产品描述 | Ly-295501 (ILX-295501) showed antitumor and anticancer activity in human pancreatic cancer xenotransplantation model.  | 
| 别名 | Ly295501, Ly 295501, ILX-295501 | 
| 分子量 | 387.24 | 
| 分子式 | C15H12Cl2N2O4S | 
| CAS No. | 150869-74-2 | 
| Smiles | S(NC(NC1=CC(Cl)=C(Cl)C=C1)=O)(=O)(=O)C=2C=C3C(=CC2)OCC3 | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 45 mg/mL (116.21 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||||||||||||
评论内容